| Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of … AJ Rodger, V Cambiano, T Bruun, P Vernazza, S Collins, O Degen, ... The Lancet 393 (10189), 2428-2438, 2019 | 1029 | 2019 |
| Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patients R Walli, O Herfort, GM Michl, T Demant, H Jäger, C Dieterle, JR Bogner, ... Aids 12 (15), F167-F173, 1998 | 624 | 1998 |
| Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study JP Viard, JC Souberbielle, O Kirk, J Reekie, B Knysz, M Losso, J Gatell, ... Aids 25 (10), 1305-1315, 2011 | 246 | 2011 |
| Impact of CYP2B6 983T>C polymorphism on non-nucleoside reverse transcriptase inhibitor plasma concentrations in HIV-infected patients C Wyen, H Hendra, M Vogel, C Hoffmann, H Knechten, NH Brockmeyer, ... Journal of antimicrobial chemotherapy 61 (4), 914-918, 2008 | 205 | 2008 |
| Chronic progressive HIV-1 infection is associated with elevated levels of myeloid-derived suppressor cells T Vollbrecht, R Stirner, A Tufman, J Roider, RM Huber, JR Bogner, ... Aids 26 (12), F31-F37, 2012 | 173 | 2012 |
| Stavudine versus zidovudine and the development of lipodystrophy JR Bogner, V Vielhauer, RA Beckmann, G Michl, L Wille, B Salzberger, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 27 (3), 237-244, 2001 | 151 | 2001 |
| Evaluation of Diagnostic Value and Epidemiological Implications of PCR for Pneumocystis carinii in Different Immunosuppressed and Immunocompetent Patient … A Sing, K Trebesius, A Roggenkamp, H Rüssmann, K Tybus, F Pfaff, ... Journal of clinical microbiology 38 (4), 1461-1467, 2000 | 140 | 2000 |
| An unusual cluster of cases of Castleman's disease during highly active antiretroviral therapy for AIDS C Zietz, JR Bogner, FD Goebel, U Löhrs New England Journal of Medicine 340 (24), 1923-1924, 1999 | 137 | 1999 |
| Cytochrome P450 2B6 (CYP2B6) and constitutive androstane receptor (CAR) polymorphisms are associated with early discontinuation of efavirenz-containing … C Wyen, H Hendra, M Siccardi, M Platten, H Jaeger, T Harrer, S Esser, ... Journal of antimicrobial chemotherapy 66 (9), 2092-2098, 2011 | 129 | 2011 |
| Efficacy and safety of dolutegravir–rilpivirine for maintenance of virological suppression in adults with HIV-1: 100-week data from the randomised, open-label, phase 3 SWORD-1 … M Aboud, C Orkin, D Podzamczer, JR Bogner, D Baker, ... The lancet HIV 6 (9), e576-e587, 2019 | 122 | 2019 |
| A retrospective analysis of weight changes in HIV-positive patients switching from a tenofovir disoproxil fumarate (TDF)-to a tenofovir alafenamide fumarate (TAF)-containing … M Gomez, U Seybold, J Roider, G Härter, JR Bogner Infection 47, 95-102, 2019 | 111 | 2019 |
| Overnight resting of PBMC changes functional signatures of antigen specific T-cell responses: impact for immune monitoring within clinical trials S Kutscher, CJ Dembek, S Deckert, C Russo, N Körber, JR Bogner, ... PloS one 8 (10), e76215, 2013 | 80 | 2013 |
| Safety and efficacy of the HIV-1 attachment inhibitor prodrug BMS-663068 in treatment-experienced individuals: 24 week results of AI438011, a phase 2b, randomised controlled trial JP Lalezari, GH Latiff, C Brinson, J Echevarría, S Treviño-Pérez, ... The lancet HIV 2 (10), e427-e437, 2015 | 75 | 2015 |
| Outlook in oral and cutaneous Kaposi's sarcoma B Rohrmus, EM Thoma-Greber, JR Bogner, M Röcken The Lancet 356 (9248), 2160, 2000 | 75 | 2000 |
| Poor outcome of HIV-infected patients with plasmablastic lymphoma: results from the German AIDS-related lymphoma cohort study P Schommers, C Wyen, M Hentrich, D Gillor, A Zoufaly, B Jensen, ... Aids 27 (5), 842-845, 2013 | 74 | 2013 |
| Survival of AIDS‐related diffuse large B‐cell lymphoma, Burkitt lymphoma, and plasmablastic lymphoma in the German HIV Lymphoma Cohort P Schommers, M Hentrich, C Hoffmann, D Gillor, A Zoufaly, B Jensen, ... British journal of haematology 168 (6), 806-810, 2015 | 63 | 2015 |
| Changes in cardiovascular disease risk factors with immediate versus deferred antiretroviral therapy initiation among HIV‐positive participants in the START (Strategic Timing … JV Baker, S Sharma, AC Achhra, JI Bernardino, JR Bogner, D Duprez, ... Journal of the American Heart Association 6 (5), e004987, 2017 | 58 | 2017 |
| Kinetics of human myeloid-derived suppressor cells after blood draw E Grützner, R Stirner, L Arenz, AP Athanasoulia, K Schrödl, C Berking, ... Journal of translational medicine 14, 1-7, 2016 | 45 | 2016 |
| The “Choosing Wisely” initiative in infectious diseases C Lehmann, R Berner, JR Bogner, OA Cornely, K de With, S Herold, ... Infection 45, 263-268, 2017 | 41 | 2017 |
| Safety, efficacy, and dose response of the maturation inhibitor GSK3532795 (formerly known as BMS-955176) plus tenofovir/emtricitabine once daily in treatment-naive HIV-1 … J Morales-Ramirez, JR Bogner, JM Molina, J Lombaard, IB Dicker, ... PLoS One 13 (10), e0205368, 2018 | 36 | 2018 |
